The role of FGFR2 amplification and expression in patients with advanced or metastatic gastric cancer receiving fluoropyrimidine-based chemotherapy

被引：0
|
作者：
Skupinska, M. M. [1 ]
Jesiotr, M. [2 ]
Chrom, P. [3 ]
Mroz, A. [4 ]
Cierniak, S. [2 ]
Winiarek, M. [5 ]
Wyrwicz, L. S. [5 ]
Pieczykolan, J. [6 ]
Wieczorek, M. [7 ]
Stanczak, A. [1 ]
Bodnar, L. [3 ]
机构：
[1] Celon Pharma, Preclin Dev Dept, Warsaw, Poland
[2] Mil Inst Med, Dept Pathol, Warsaw, Poland
[3] Mil Inst Med, Dept Oncol, Warsaw, Poland
[4] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol & Lab Diagnost, Warsaw, Poland
[5] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Oncol & Radiotherapy, Warsaw, Poland
[6] Celon Pharma, Preclin Dev Dept, Lomianki, Poland
[7] Celon Pharma SA, Lomianki, Poland
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
647P
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [1] The prognostic impact of FGFR2 gene amplification in patients receiving fluoropyrimidine and platinum (FP) chemotherapy for with metastatic and locally advanced gastric cancers
    Seo, S.
    Park, S. J.
    Park, S. R.
    Ryu, M. H.
    Ryoo, B. Y.
    Park, Y. S.
    Na, Y. S.
    Lee, C. W.
    Lee, J. K.
    Kang, Y. K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S472 - S472
  • [2] Amplification of FGFR2 Gene in Patients with Advanced Gastric Cancer Receiving Chemotherapy: Prevalence and Prognostic Significance
    Shoji, Hirokazu
    Yamada, Yasuhide
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    ANTICANCER RESEARCH, 2015, 35 (09) : 5055 - 5061
  • [3] A PHASE 2 TRIAL OF IXABEPILONE IN ASIAN PATIENTS WITH ADVANCED GASTRIC CANCER PREVIOUSLY TREATED WITH FLUOROPYRIMIDINE-BASED CHEMOTHERAPY
    Yasui, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 19 - 19
  • [4] Capecitabine "metronomic" chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy
    He, ShengLi
    Shen, Jie
    Hong, Liang
    Niu, LuMing
    Niu, DaoYong
    MEDICAL ONCOLOGY, 2012, 29 (01) : 100 - 106
  • [5] Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy
    ShengLi He
    Jie Shen
    Liang Hong
    LuMing Niu
    DaoYong Niu
    Medical Oncology, 2012, 29 : 100 - 106
  • [6] Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy
    Pereira, Marina Alessandra
    Kodama Pertille Ramos, Marcus Fernando
    Dias, Andre Roncon
    Faraj, Sheila Friedrich
    Cirqueira, Cinthya dos Santos
    de Mello, Evandro Sobroza
    Zilberstein, Bruno
    Ferreira Alves, Venancio Avancini
    Ribeiro, Ulysses, Jr.
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (05) : 526 - 536
  • [7] Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy
    Marina Alessandra Pereira
    Marcus Fernando Kodama Pertille Ramos
    ANDre Roncon Dias
    Sheila Friedrich Faraj
    Cinthya dos Santos Cirqueira
    EvANDro Sobroza de Mello
    Bruno Zilberstein
    Venancio Avancini Ferreira Alves
    Ulysses Ribeiro Jr
    ChineseJournalofCancerResearch, 2018, 30 (05) : 526 - 536
  • [8] Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
    Kim, Seung
    Won, Young-Woong
    Kim, Jung Hoon
    Park, Joon Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [9] Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin)
    Kim, Seung Tae
    Ahn, Soomin
    Lee, Jeeyun
    Lee, Su Jin
    Park, Se Hoon
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Kyoung-Mee
    Park, Joon Oh
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1231 - 1237
  • [10] Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin)
    Seung Tae Kim
    Soomin Ahn
    Jeeyun Lee
    Su Jin Lee
    Se Hoon Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    Kyoung-Mee Kim
    Joon Oh Park
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1231 - 1237
12345